Edge Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Edge Asset Management's NVS Position: Q1 2017 in Review
Edge Asset Management increased its Novartis (NVS) stake by 0.01% in Q1 2017, buying an estimated $7.46K and bringing the position to 1,142,575 shares worth $76M. The position accounts for 0.57% of the portfolio, ranked #62.
Edge Asset Management first reported a position in NVS in Q2 2013 and has held it in 16 quarters since. The position peaked at $83M in Q2 2014. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.
- Edge Asset Management held 1,142,575 shares of Novartis worth $76M as of Q1 2017.
- Edge Asset Management bought 112 Novartis shares in Q1 2017, an estimated $7.46K.
- Novartis made up 0.57% of Edge Asset Management's portfolio in Q1 2017, its #62 holding.
- Edge Asset Management first reported a position in Novartis in Q2 2013 and has held it in 16 quarters since.
- Edge Asset Management's Novartis position peaked at $83M in Q2 2014.
- 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.
Based on Edge Asset Management's 13F filing for Q1 2017, filed 11 May 2017.